| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ACTIVATION OF MK2 IN CROHN’S DISEASE-ASSOCIATED FIBROSIS: NEW TARGET FOR ANTI-FIBROTIC THERAPY
|
Chulkina, Marina
|
|
|
162 |
3S |
p. S62
|
artikel
|
| 2 |
ACUITY OF PEDIATRIC INFLAMMATORY BOWEL DISEASE ADMISSIONS PRE AND DURING THE COVID-19 PANDEMIC
|
Waschmann, Malika
|
|
|
162 |
3S |
p. S31
|
artikel
|
| 3 |
ADDITIVE EFFECT OF PROBIOTICS ON 5-AMINOSALICYLIC ACID THERAPY IN PATIENT WITH ULCERATIVE COLITIS
|
Kim, Minjun
|
|
|
162 |
3S |
p. S13-S14
|
artikel
|
| 4 |
ADEQUACY OF SIGMOIDOSCOPY IN COMPARISION TO COLONOSCOPY TO ASSESS DISEASE ACTIVITY DURING FOLLOW UP IN PATIENTS WITH ULCERATIVE COLITIS
|
Patel, Sameet
|
|
|
162 |
3S |
p. S31-S32
|
artikel
|
| 5 |
ADHERENT-INVASIVE E. COLI PROMOTE ER STRESS TO SUPPORT IL23R-DRIVEN AGR2-DEPENDENT ILEOCOLITIS
|
Viladomiu, Monica
|
|
|
162 |
3S |
p. S55
|
artikel
|
| 6 |
ADVERSE CLINICAL OUTCOMES IN PATIENTS WITH CROHN’S DISEASE RECEIVING DIFFERENT SEQUENCES OF FIRST- AND SECOND-LINE BIOLOGIC TREATMENTS: FINDINGS FROM ROTARY
|
Cleveland, Noa
|
|
|
162 |
3S |
p. S7-S8
|
artikel
|
| 7 |
ADVERSE CLINICAL OUTCOMES IN PATIENTS WITH ULCERATIVE COLITIS RECEIVING DIFFERENT SEQUENCES OF FIRST- AND SECOND-LINE BIOLOGIC TREATMENTS: FINDINGS FROM ROTARY
|
Cleveland, Noa
|
|
|
162 |
3S |
p. S8-S9
|
artikel
|
| 8 |
AHR EXPRESSION ON VIL1-EXPRESSING COLONIC EPITHELIAL CELLS IS ESSENTIAL FOR I3C-MEDIATED PROTECTION AGAINST COLITIS
|
Saxena, Archana
|
|
|
162 |
3S |
p. S1-S2
|
artikel
|
| 9 |
ALTERED MICROBIAL BIOGEOGRAPHY IN INNATE IMMUNE-MEDIATED COLITIS
|
Boger-May, Antonia
|
|
|
162 |
3S |
p. S55-S56
|
artikel
|
| 10 |
AMINO ACID SENSING PATHWAYS IN INFLAMMATORY BOWEL DISEASE
|
Solanki, Sumeet
|
|
|
162 |
3S |
p. S23-S24
|
artikel
|
| 11 |
ANEMIA TREATMENT PATTERNS AND OUTCOMES AMONG A NATIONAL COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
|
Brooks, Carolyn
|
|
|
162 |
3S |
p. S36-S37
|
artikel
|
| 12 |
A NEWLY DISCOVERED REGULATORY CD8 T CELL NETWORK HAS THE POTENTIAL TO REGULATE AND ELIMINATE PATHOGENIC CD4 T CELLS IN AUTOIMMUNE MEDIATED DISEASE OF THE GUT
|
Crane, Courtney
|
|
|
162 |
3S |
p. S55
|
artikel
|
| 13 |
AN ONLINE SURVEY AMONG US PATIENTS WITH IMMUNE-MEDIATED CONDITIONS: BELIEFS ABOUT BIOSIMILARS FROM PATIENTS WITH INFLAMMATORY BOWEL DISEASE
|
Jacobson, Gary
|
|
|
162 |
3S |
p. S101
|
artikel
|
| 14 |
A NOVEL MICROBIALLY-DERIVED PROTEIN CAN BE EXPRESSED IN LACTOCOCCUS LACTIS AND DELIVERED ORALLY TO IMPROVE GUT BARRIER FUNCTION AND PREVENT FIBROGENESIS BY INTERACTING WITH THE EXTRACELLULAR MATRIX DURING GI INJURY
|
La Chat, Chip
|
|
|
162 |
3S |
p. S61
|
artikel
|
| 15 |
A NOVEL ORALLY ACTIVE METABOLITE REVERSES CROHN'S DISEASE-ASSOCIATED INTESTINAL FIBROSIS
|
Koon, Hon Wai
|
|
|
162 |
3S |
p. S61-S62
|
artikel
|
| 16 |
ANTI-SARS-COV-2 VACCINATION AND ANTIBODY RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON IMMUNE-MODIFYING THERAPY. PROSPECTIVE SINGLE TERTIARY CENTER STUDY ON 602 IBD PATIENTS
|
Cerna, Karin
|
|
|
162 |
3S |
p. S101-S102
|
artikel
|
| 17 |
A QUALITATIVE STUDY EXPLORING MEANINGFUL IMPROVEMENT IN BOWEL URGENCY AMONG ADULTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
|
Newton, Louise
|
|
|
162 |
3S |
p. S86-S87
|
artikel
|
| 18 |
AUPHOS, A “FIRST-IN CLASS” ORAL AGENT FOR CORRECTING METABOLIC DYSFUNCTION IN IBD
|
Wempe, Lesley
|
|
|
162 |
3S |
p. S2
|
artikel
|
| 19 |
AUPHOS, A NOVEL THERAPEUTIC THAT IMPROVES MITOCHONDRIAL FUNCTION AND AMELIORATES CHRONIC COLITIS
|
Mohamed, Rana
|
|
|
162 |
3S |
p. S2-S3
|
artikel
|
| 20 |
AUTOMATIC BLEEDING AND ULCER DETECTION FROM LIMITED QUALITY ANNOTATIONS IN ULCERATIVE COLITIS
|
Al-Ali, Safaa
|
|
|
162 |
3S |
p. S19-S20
|
artikel
|
| 21 |
BEZLOTOXUMAB THERAPY FOR RECURRENT CLOSTRIDIUM DIFFICILE INFECTION IN AN ULCERATIVE COLITIS PATIENT
|
Fein, Aaron
|
|
|
162 |
3S |
p. S102
|
artikel
|
| 22 |
BIOLOGICAL THERAPY AND POST-OPERATIVE OUTCOMES IN CROHN'S DISEASE PATIENTS UNDERGOING REPEAT ILEOCOLIC RESECTION
|
Horesh, Nir
|
|
|
162 |
3S |
p. S102-S103
|
artikel
|
| 23 |
BIOLOGIC PRECISION DOSING IS NOW AVAILABLE AT THE BEDSIDE FOR CHILDREN AND ADULTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING INFLIXIMAB
|
Minar, Phillip
|
|
|
162 |
3S |
p. S98-S99
|
artikel
|
| 24 |
BRAIN FOG IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE, AND ASSOCIATION WITH USE OF PROBIOTICS
|
Dadlani, Apaar
|
|
|
162 |
3S |
p. S66-S67
|
artikel
|
| 25 |
BURDEN OF ILLNESS OF OSTEOPOROTIC FRACTURES COMPARED TO OTHER SERIOUS DISEASES AMONG IBD PATIENTS
|
Tariq, Raseen
|
|
|
162 |
3S |
p. S37
|
artikel
|
| 26 |
BURDEN OF NON-ALCOHOLIC FATTY LIVER DISEASE AMONG PATIENTS WITH CROHN’S DISEASE: ANALYSIS OF THE NATIONWIDE READMISSION DATABASE
|
Abomhya, Ahmed
|
|
|
162 |
3S |
p. S37-S38
|
artikel
|
| 27 |
CELL-AUTONOMOUS HEDGEHOG SIGNALING CONTROLS TH17 DIFFERENTIATION TO DRIVE INTESTINAL INFLAMMATION AND IS A DRUGGABLE TARGET FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
|
Hanna, Joachim
|
|
|
162 |
3S |
p. S3
|
artikel
|
| 28 |
CELLULAR AND MOLECULAR IMPACT OF THE MELANOCORTIN RECEPTOR AGONIST PL8177 IN DEXTRAN SODIUM SULFATE (DSS)-INDUCED COLITIS IN RATS
|
Dhingra, Priyanka
|
|
|
162 |
3S |
p. S3
|
artikel
|
| 29 |
CHANGE IN URGENCY STATUS AMONG ULCERATIVE COLITIS PATIENTS: UNDERSTANDING THE IMPACT OF TREATMENT CHANGES FROM THE COREVITAS INFLAMMATORY BOWEL DISEASE REGISTRY
|
Wolf, Douglas
|
|
|
162 |
3S |
p. S87
|
artikel
|
| 30 |
CHRONIC COLITIS ALTERS BRAIN ACTIVITY BY INDUCING HMGB1-MEDIATED PYROPTOSIS IN MICE
|
Mitchell, Jonathon
|
|
|
162 |
3S |
p. S56
|
artikel
|
| 31 |
CHRONIC COLITIS IN MICE INDUCES KIDNEY INJURY: TRANSLATIONAL IMPLICATIONS FOR IBD
|
Ducasa, Gloria
|
|
|
162 |
3S |
p. S38
|
artikel
|
| 32 |
CLINICAL FEATURES AND OUTCOMES OF PAEDIATRIC PATIENTS WITH ISOLATED COLONIC CROHN’S DISEASE: A MULTICENTRE STUDY FROM THE PAEDIATRIC IBD PORTO GROUP OF ESPGHAN
|
Berger, Tal
|
|
|
162 |
3S |
p. S71-S72
|
artikel
|
| 33 |
COMBINATION BIOLOGIC AND SMALL MOLECULE THERAPY FOR REFRACTORY ULCERATIVE COLITIS
|
Hickman, Kaitlyn
|
|
|
162 |
3S |
p. S103
|
artikel
|
| 34 |
COMBINATION USTEKINUMAB AND VEDOLIZUMAB THERAPY FOR REFRACTORY INFLAMMATORY BOWEL DISEASE: A SINGLE INSTITUTION CASE SERIES
|
Dawoud, Nabila
|
|
|
162 |
3S |
p. S103-S104
|
artikel
|
| 35 |
COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY: BURDEN AND IMPACT OF BOWEL URGENCY ON PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
|
Schreiber, Stefan
|
|
|
162 |
3S |
p. S79
|
artikel
|
| 36 |
COMPARING THE GUT METABOLOMIC PROFILES IN HISPANIC AND NON-HISPANIC PEDIATRIC ULCERATIVE COLITIS PATIENTS
|
Hosseini, Parastou Khalessi
|
|
|
162 |
3S |
p. S67
|
artikel
|
| 37 |
COMPARISON OF THE INFLAMMATORY BOWEL DISEASES PHENOTYPE AND COURSE IN THE ELDERLY- AND EARLY-ONSET PATIENTS
|
Saberzadeh-Ardestani, Bahar
|
|
|
162 |
3S |
p. S72
|
artikel
|
| 38 |
COMPLICATIONS OF MYOCARDITIS IN INFLAMMATORY BOWEL DISEASE (IBD): A POPULATION-BASED COMPARATIVE STUDY BETWEEN ULCERATIVE COLITIS AND CROHN'S DISEASE
|
Dasu, Neethi
|
|
|
162 |
3S |
p. S38-S39
|
artikel
|
| 39 |
CONCORDANCE BETWEEN REMISSION DEFINED BY PATIENTS VS PATIENT-REPORTED OUTCOME MEASURES IN INFLAMMATORY BOWEL DISEASE
|
Kamp, Kendra
|
|
|
162 |
3S |
p. S79-S80
|
artikel
|
| 40 |
CORRELATION OF FECAL, PLASMA, SERUM, AND SALIVARY CALPROTECTIN TO ENDOSCOPIC AND HISTOLOGIC OUTCOMES IN PATIENTS WITH CROHN’S DISEASE
|
Kamp, Kendra
|
|
|
162 |
3S |
p. S32
|
artikel
|
| 41 |
CORRELATION OF PUCAI BETWEEN MAYO ENDOSCOPIC AND GEBOES PATHOLOGY SCORES IN ASSESSING DISEASE ACTIVITY OF PEDIATRIC PATIENTS WITH UC AMONG HISPANICS AND NON-HISPANICS
|
Durazo, Francisco
|
|
|
162 |
3S |
p. S33
|
artikel
|
| 42 |
CORTICOSTEROIDS AND 5ASA VERSUS CORTICOSTEROIDS ALONE FOR ACUTE SEVERE ULCERATIVE COLITIS: A RANDOMIZED CONTROLLED TRIAL
|
Ben-Horin, Shomron
|
|
|
162 |
3S |
p. S14
|
artikel
|
| 43 |
COST-EFFECTIVENESS OF TOFACITINIB FOR THE TREATMENT OF MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS IN COLOMBIA
|
Gil, Fabio
|
|
|
162 |
3S |
p. S44
|
artikel
|
| 44 |
Cover
|
|
|
|
162 |
3S |
p. OFC
|
artikel
|
| 45 |
Cover
|
|
|
|
162 |
3S |
p. i
|
artikel
|
| 46 |
COVID-19 INFECTIONS IN VACCINATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OUTCOMES AND RISK FACTORS FOR SEVERE DISEASE
|
Spiera, Emily
|
|
|
162 |
3S |
p. S104-S105
|
artikel
|
| 47 |
CROHN'S DISEASE AND ACUTE PANCREATITIS; ASSOCIATION, OUTCOMES, AND PREDICTORS OF 90-DAY READMISSION WITH ACUTE PANCREATITIS. INSIGHTS FROM THE NATIONWIDE READMISSION DATABASE
|
Abomhya, Ahmed
|
|
|
162 |
3S |
p. S39-S40
|
artikel
|
| 48 |
CROHN’S DISEASE COMPLICATED BY ILEOSIGMOID FISTULA: ASSESSMENT AND MANAGEMENT UPDATE
|
Benammi, Sarah
|
|
|
162 |
3S |
p. S80-S81
|
artikel
|
| 49 |
CURRENT VENOUS THROMBOEMBOLISM CHEMOPROPHYLAXIS PRACTICES AFTER SURGERY FOR IBD: SAVES-IBD TRIAL INITIAL REPORT
|
Holubar, Stefan
|
|
|
162 |
3S |
p. S40
|
artikel
|
| 50 |
DECONSTRUCTING DISTRESS: STAKEHOLDER ENGAGEMENT FOR EVIDENCE-BASED, PATIENT-CENTERED INTERVENTIONS FOR THE MANAGEMENT OF IBD-ASSOCIATED PSYCHOLOGICAL DISTRESS
|
Heisler, Courtney
|
|
|
162 |
3S |
p. S88
|
artikel
|
| 51 |
DECREASED EXPRESSION OF NHE3 IN COLON CANCER EPITHELIUM IS ASSOCIATED WITH DNA DAMAGE, INCREASED LOCAL INFLAMMATION AND TUMOR GROWTH
|
Laubitz, Daniel
|
|
|
162 |
3S |
p. S49
|
artikel
|
| 52 |
DEVELOPMENT AND VALIDATION OF A MACHINE LEARNING TOOL FOR EARLY DIAGNOSIS OF INFLAMMATORY BOWEL DISEASE IN THE PRIMARY CARE SETTING: A POPULATION BASED STUDY
|
Ber, Tahel Ilan
|
|
|
162 |
3S |
p. S20-S21
|
artikel
|
| 53 |
DEVELOPMENT AND VALIDATION OF THE CROHN'S DISEASE-HEALTH INDEX (CD-HI), A CLINICALLY-RELEVANT, DISEASE-SPECIFIC PATIENT-REPORTED OUTCOME MEASURE
|
Seabury, Jamison
|
|
|
162 |
3S |
p. S73
|
artikel
|
| 54 |
DIET AND ITS MICROENVIRONMENT INFLUENCE THE HEALTH OF COLON
|
Thomas, Sunil
|
|
|
162 |
3S |
p. S3-S4
|
artikel
|
| 55 |
DIET-ASSOCIATED INFLAMMATION, PHYSICAL ACTIVITY, AND HEALTH-RELATED OUTCOMES IN ULCERATIVE COLITIS
|
DuBois, Kelli
|
|
|
162 |
3S |
p. S24
|
artikel
|
| 56 |
DISCOVERY OF IBD3540: A NOVEL GUT-RESTRICTED GLUTAMATE CARBOXYPEPTIDASE II INHIBITOR WITH ORAL ACTIVITY IN MOUSE COLITIS MODELS
|
Peters, Diane
|
|
|
162 |
3S |
p. S4
|
artikel
|
| 57 |
DOSE ESCALATION OF BIOLOGIC THERAPIES IN BIOLOGIC TREATMENT-NAÏVE ADULT PATIENTS WITH ULCERATIVE COLITIS: RESULTS FROM THE ODESSA DATABASE STUDY
|
Kathe, Niranjan
|
|
|
162 |
3S |
p. S9-S10
|
artikel
|
| 58 |
DUAL BIOLOGICAL OR SMALL MOLECULE TREATMENT IN INFLAMMATORY BOWEL DISEASES: DATA FROM CLINICAL PRACTICE
|
Lukas, Milan
|
|
|
162 |
3S |
p. S105
|
artikel
|
| 59 |
EARLY VERSUS DELAYED INITIATION OF VEDOLIZUMAB IN ULCERATIVE COLITIS: TREATMENT RESPONSE IN THE REAL WORLD (RALEE)
|
Cleveland, Noa
|
|
|
162 |
3S |
p. S105-S106
|
artikel
|
| 60 |
EFFECTIVENESS OF ANTI-TNF THERAPY COMPARED TO IMMUNE MODULATOR FOR PREVENTION OF SURGICAL RECURRENCE IN PEDIATRIC CD
|
Egberg, Matthew
|
|
|
162 |
3S |
p. S10-S11
|
artikel
|
| 61 |
EFFECTIVENESS OF CROHN’S DISEASE EXCLUSION DIET FOR INDUCTION OF REMISSION IN CROHN’S DISEASE ADULT PATIENTS
|
Szczubelek, Martyna
|
|
|
162 |
3S |
p. S24-S25
|
artikel
|
| 62 |
EFFECTS OF DELAYED ENDOSCOPIES IN INFLAMMATORY BOWEL DISEASE PATIENTS DURING THE COVID-19 PANDEMIC
|
Young, Karen
|
|
|
162 |
3S |
p. S81
|
artikel
|
| 63 |
EFFICACY OF A DIGITALLY DELIVERED PERSONALIZED ELIMINATION DIET FOR THE SELF-MANAGEMENT OF INFLAMMATORY BOWEL DISEASE AND IRRITABLE BOWEL SYNDROME
|
Jactel, Samuel
|
|
|
162 |
3S |
p. S25
|
artikel
|
| 64 |
EFFICACY OF BIOLOGIC DRUGS IN SHORT-DURATION VERSUS LONG-DURATION INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND INDVIDUAL-PATIENT-DATA METANALYSIS OF RANDOMIZED CONTROLLED TRIALS
|
Ben-Horin, Shomron
|
|
|
162 |
3S |
p. S11
|
artikel
|
| 65 |
EFFICACY OF LOW DOSE NALTREXONE IN PATIENTS WITH CROHN’S COLITIS AND ILEITIS
|
Weinstock, Leonard
|
|
|
162 |
3S |
p. S106-S107
|
artikel
|
| 66 |
EICOSATETRAYNOIC ACID REGULATES MITOCHONDRIAL AND EXTRA-CELLULAR MATRIX GENE EXPRESSION AND TISSUE STIFFNESS IN A HUMAN INTESTINAL ORGANOID MODEL OF ILEAL CROHN’S DISEASE
|
Jurickova, Ingrid
|
|
|
162 |
3S |
p. S62-S63
|
artikel
|
| 67 |
ENDOSCOPIC STRICTUROTOMY – A NOVEL THERAPEUTIC MODALITY FOR IBD-RELATED STRICTURES: FIRST EUROPEAN EXPERIENCE
|
Lukas, Martin
|
|
|
162 |
3S |
p. S40-S41
|
artikel
|
| 68 |
ENHANCED RECOVERY PROGRAMS: HOW ARE WE BENEFITTING PATIENTS WITH IBD?
|
Shao, Connie
|
|
|
162 |
3S |
p. S81-S82
|
artikel
|
| 69 |
EPITHELIAL DUOX2 ACTIVATION INCREASES GUT PERMEABILITY AND BACTERIAL TRANSLOCATION THAT IS RESCUED WITH BUTYRATE SUPPLEMENTATION
|
Hazime, Hajar
|
|
|
162 |
3S |
p. S49
|
artikel
|
| 70 |
EQUIVALENT ADVERSE OUTCOMES FOR HOME AND HOSPITAL-BASED INFUSIONS OF INFLIXIMAB IN CHILDREN AND ADOLESCENTS WITH INFLAMMATORY BOWEL DISEASE
|
Gupta, Shivani
|
|
|
162 |
3S |
p. S1
|
artikel
|
| 71 |
EVALUATING THE IMPACT OF THE COVID-19 PANDEMIC ON URGENT MEDICAL ACCESS FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE AT A PRIVATE COMMUNITY GASTROENTEROLOGY PRACTICE
|
Kwon, Michelle
|
|
|
162 |
3S |
p. S82
|
artikel
|
| 72 |
EXPLORING SELF-MANAGEMENT CHALLENGES OF ADOLESCENTS AND YOUNG ADULTS WITH INFLAMMATORY BOWEL DISEASE IN AN ONLINE INSTAGRAM SUPPORT COMMUNITY
|
Malloy, Caeli
|
|
|
162 |
3S |
p. S88-S89
|
artikel
|
| 73 |
FEAR OF THE COVID-19 PANDEMIC IN ADOLESCENTS AND YOUNG ADULTS WITH INFLAMMATORY BOWEL DISEASE: RELATIONSHIP TO PSYCHOLOGICAL AND PHYSICAL OUTCOMES
|
Neiman, Nicole
|
|
|
162 |
3S |
p. S89-S90
|
artikel
|
| 74 |
FECAL CALPROTECTIN TESTING: AN INVESTIGATION OF PATIENT COMPLIANCE AND PERCEPTIONS
|
Perry, Courtney
|
|
|
162 |
3S |
p. S90
|
artikel
|
| 75 |
FECAL MICROBIOTA OF PEOPLE WITH CROHN'S DISEASE DOES NOT CHANGE WITH ILEOCECAL RESECTION
|
Moutsoglou, Daphne
|
|
|
162 |
3S |
p. S67-S68
|
artikel
|
| 76 |
GENERATION OF ANTIGEN-SPECIFIC REGULATORY T CELLS BY LACTOBACILLUS SPECIES
|
Weingarden, Alexa
|
|
|
162 |
3S |
p. S4-S5
|
artikel
|
| 77 |
GENERATION OF HUMAN INTESTINAL ORGANOIDS CONTAINING TISSUE-RESIDENT IMMUNE CELLS
|
Tominaga, Kentaro
|
|
|
162 |
3S |
p. S57
|
artikel
|
| 78 |
GENETIC OVERLAP BETWEEN INFLAMMATORY BOWEL DISEASE AND PARKINSON'S DISEASE IMPLICATES THE ROLE OF ADAPTIVE IMMUNE RESPONSE IN THEIR COMORBIDITY
|
Otten, Thomas
|
|
|
162 |
3S |
p. S53-S54
|
artikel
|
| 79 |
GEOGRAPHIC DIFFERENCES IN THE RISK OF SURGERY IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
|
Hansen, Tawnya
|
|
|
162 |
3S |
p. S44-S45
|
artikel
|
| 80 |
GLOBAL HOSPITALIZATION TRENDS FOR CROHN’S DISEASE AND ULCERATIVE COLITIS: SYSTEMATIC REVIEW WITH TEMPORAL ANALYSES
|
Buie, Michael
|
|
|
162 |
3S |
p. S45-S46
|
artikel
|
| 81 |
GPX3 IS REQUIRED TO MEDIATE PROTECTIVE EFFECTS OF GPX1 LOSS IN COLITIS
|
Blunt, Koral
|
|
|
162 |
3S |
p. S63
|
artikel
|
| 82 |
HIGH DOSE TOFACITINIB AS SALVAGE THERAPY IN STEROID REFRACTORY ACUTE SEVERE ULCERATIVE COLITIS FOLLOWING NON-RESPONSE TO INFLIXIMAB
|
Khan, Muhammad
|
|
|
162 |
3S |
p. S107
|
artikel
|
| 83 |
IBD AND THE PATIENT-PROVIDER RELATIONSHIP: DOES TRUST IMPACT TELEMEDICINE UTILIZATION?
|
Katta, Meghna
|
|
|
162 |
3S |
p. S83
|
artikel
|
| 84 |
IBD MIMICS PRESENTED AT IBD LIVE: WHEN IT IS NOT INFLAMMATORY BOWEL DISEASE
|
Ward, Christopher
|
|
|
162 |
3S |
p. S83-S84
|
artikel
|
| 85 |
IDENTIFYING BARRIERS TO HEALTH MAINTENANCE IN MEDICALLY-UNDERSERVED PATIENTS WITH IBD: A QUALITATIVE STUDY
|
Belton, Juanita
|
|
|
162 |
3S |
p. S90-S91
|
artikel
|
| 86 |
IDENTIFYING THE MOST EFFECTIVE TREATMENT ALGORITHM FOR THERAPIES TO TREAT MODERATE TO SEVERE ULCERATIVE COLITIS
|
Scott, Frank
|
|
|
162 |
3S |
p. S11-S12
|
artikel
|
| 87 |
ILEAL ENTEROCYTE BRUSH BORDER ABNORMALITIES ASSOCIATE WITH PROGRESSIVE DISEASE COURSE IN PEDIATRICS CROHN’S DISEASE
|
Haberman, Yael
|
|
|
162 |
3S |
p. S49-S50
|
artikel
|
| 88 |
IMPACT OF CURRENT AND FORMER SMOKING ON THE RISK OF ULCERATIVE COLITIS AMONG FAMILY HISTORY POSITIVE AND NEGATIVE INDIVIDUALS; EVIDENCE FOR GENE-SMOKING INTERACTION FROM LARGE SCALE POPULATION-BASED COHORT STUDY IN KOREA
|
Ahn, Hyeong Sik
|
|
|
162 |
3S |
p. S46
|
artikel
|
| 89 |
IMPACT OF THIOPURINE DOSE IN COMBINATION THERAPY IN INFLAMMATORY BOWEL DISEASE
|
Nawaz, Ahmad
|
|
|
162 |
3S |
p. S107-S108
|
artikel
|
| 90 |
IMPACT OF TIMING OF INITIATION OF INFLIXIMAB ON THE RISK OF IBD-RELATED SURGERY AND COMPLICATIONS
|
Young, Denise
|
|
|
162 |
3S |
p. S73
|
artikel
|
| 91 |
IMPLICATIONS OF ADOLESCENT AND PARENT PERCIEVED SKILL-BUILDING ON MISCARREID HELPING AND SELF-EFFICACY FOLLOWING A TRANSITION WORKSHOP FOR ADOLESCENTS WITH INFLAMMATORY BOWEL DISEASE
|
Waschmann, Malika
|
|
|
162 |
3S |
p. S84
|
artikel
|
| 92 |
IMPROVING THE VACCINATION RATES FOR IMMUNOSUPPRESSED PATIENTS WITH INFLAMMATORY BOWEL DISEASE
|
Cheng, Tony
|
|
|
162 |
3S |
p. S84-S85
|
artikel
|
| 93 |
INCIDENCE AND PREVALENCE OF PRIMARY SCLEROSING CHOLANGITIS: A META-ANALYSIS OF POPULATION-BASED STUDIES
|
Cooper, Jared
|
|
|
162 |
3S |
p. S46-S47
|
artikel
|
| 94 |
INCIDENTALLY DIAGNOSED ASYMPTOMATIC CROHN'S DISEASE: LONG-TERM CLINICAL OUTCOMES OF UNTREATED PATIENTS
|
Grinman, Ana
|
|
|
162 |
3S |
p. S74
|
artikel
|
| 95 |
INCREASED PREVALENCE OF ANXIETY IN HOSPITALIZED CROHN'S DISEASE PATIENTS IN THE UNITED STATES: INSIGHTS FROM NATIONAL INPATIENT DATABASE FROM 2009 TO 2018
|
Bhurwal, Abhishek
|
|
|
162 |
3S |
p. S91
|
artikel
|
| 96 |
INCREASE IN MK2 ACTIVITY IN CROHN’S DISEASE: ROLE IN THE INFLAMMATORY ACTIVATION OF FIBROBLASTS
|
Chulkina, Marina
|
|
|
162 |
3S |
p. S63-S64
|
artikel
|
| 97 |
INFLAMMATORY BOWEL DISEASE IN APPALACHIA: AN INVESTIGATION INTO DISPARATE OUTCOMES WITHIN THE STATE OF KENTUCKY
|
Perry, Courtney
|
|
|
162 |
3S |
p. S74-S75
|
artikel
|
| 98 |
INFLAMMATORY BOWEL DISEASE RISK STRATIFICATION AND MANAGEMENT IN A COMMUNITY PRACTICE SETTING
|
Collins, Angelina
|
|
|
162 |
3S |
p. S33-S34
|
artikel
|
| 99 |
INTERLEUKIN 21-INDUCED METABOLIC REPROGRAMMING DRIVES CD4 T CELL INFLAMMATORY RESPONSE DURING INTESTINAL INFLAMMATION
|
Bamidele, Adebowale
|
|
|
162 |
3S |
p. S58
|
artikel
|
| 100 |
INTERLEUKIN-17 RECEPTOR SIGNALING TO PANETH CELLS HELPS MAINTAIN INTESTINAL INTEGRITY AFTER GAMMA RADIATION INDUCED INJURY
|
Kempen, Cody
|
|
|
162 |
3S |
p. S18-S19
|
artikel
|
| 101 |
INTESTINAL EPITHELIAL CELL-SPECIFIC CFTR KNOCKOUT MICE EXHIBIT FECAL MICROBIAL DYSBIOSIS
|
Young, Sarah
|
|
|
162 |
3S |
p. S68-S69
|
artikel
|
| 102 |
KLEBSIELLA PNEUMONIAE IN THE COLONIC MUCUS LAYER INFLUENCES CLOSTRIDIODES DIFFICILE PATHOGENESIS
|
Ticer, Taylor
|
|
|
162 |
3S |
p. S69
|
artikel
|
| 103 |
LACTOBACILLUS MURINUS ACTIVATES THE ARYL HYDROCARBON RECEPTOR TO ATTENUATE TNF-ALPHA-INDUCED PRO-INFLAMMATORY RESPONSES IN HUMAN INTESTINAL EPITHELIAL CELLS
|
Ahmed, Husnain
|
|
|
162 |
3S |
p. S65
|
artikel
|
| 104 |
LACTOCOCCUS LACTIS DELIVERY OF SURFACE LAYER PROTEIN A PROTECTS MICE FROM COLITIS BY RE-SETTING HOST IMMUNE REPERTOIRE
|
Sahay, Bikash
|
|
|
162 |
3S |
p. S5
|
artikel
|
| 105 |
LOCAL IBD-EXPERTS DISSATISFACTION WITH BIOLOGIC MEDICATION AUTHORIZATION DENIALS - A SURVEY OF SPECIFIC CLINICAL SCENARIOS
|
DeCoste, Leah
|
|
|
162 |
3S |
p. S85
|
artikel
|
| 106 |
LONGITUDINAL STUDY OF THE IMPACT OF HEALTH CONFIDENCE ON INFLAMMATORY BOWEL DISEASE OUTCOMES AND HEALTHCARE UTILIZATION
|
Tse, Chung Sang
|
|
|
162 |
3S |
p. S91-S92
|
artikel
|
| 107 |
LONG TERM ADVERSE HEALTH OUTCOMES IN OFFSPRING FROM MOTHERS WITH INFLAMMATORY BOWEL DISEASE: A NATIONWIDE POPULATION BASED STUDY IN KOREA
|
Ahn, Hyeong Sik
|
|
|
162 |
3S |
p. S75
|
artikel
|
| 108 |
LONG TERM OUTCOMES OF PARTIAL ENTERAL NUTRITION THERAPY IN CHILDREN WITH CROHN’S DISEASE
|
Vellanki, Srisindu
|
|
|
162 |
3S |
p. S26
|
artikel
|
| 109 |
MASS CYTOMETRY ANALYSIS OF CROHN’S DISEASE-LIKE PHENOTYPE OF THE ILEOANAL POUCH FOLLOWING ILEAL POUCH-ANAL ANASTOMOSIS FOR ULCERATIVE COLITIS
|
Cao, Siyan
|
|
|
162 |
3S |
p. S58-S59
|
artikel
|
| 110 |
MATRIX METALLOPROTEINASE (MMP-9) INDUCED INCREASE IN INTESTINAL EPITHELIAL TIGHT JUNCTION BARRIER IS MEDIATED BY EGFR ACTIVATION
|
Al-Sadi, Rana
|
|
|
162 |
3S |
p. S50
|
artikel
|
| 111 |
MEDICAL DECISION-MAKING AND EDUCATION RELATED TO OSTOMY SURGERY IN PEDIATRIC PATIENTS WITH IBD: QUALITATIVE THEMES FROM MULTIDISCIPLINARY PROVIDER FOCUS GROUPS
|
David, Jennie
|
|
|
162 |
3S |
p. S85-S86
|
artikel
|
| 112 |
METHYLTRANSFERASE SMYD2 MODULATES THERAPEUTIC EFFECTS OF EPIDERMAL GROWTH FACTOR IN INFLAMMATORY BOWEL DISEASE
|
Guan, Xiaoqing
|
|
|
162 |
3S |
p. S50-S51
|
artikel
|
| 113 |
MICROSCOPIC COLITIS IS ASSOCIATED WITH DECREASED BONE DENSITY: A SYSTEMATIC REVIEW AND META-ANALYSIS
|
Chaisidhivej, Natapat
|
|
|
162 |
3S |
p. S41
|
artikel
|
| 114 |
MIRIKIZUMAB IMPROVES PATIENT ASSESSMENT OF DISEASE SEVERITY AND CHANGE IN DISEASE ACTIVITY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE
|
Rubin, David
|
|
|
162 |
3S |
p. S14-S15
|
artikel
|
| 115 |
MIRIKIZUMAB REDUCES ABDOMINAL PAIN IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE
|
Loftus, Edward
|
|
|
162 |
3S |
p. S15
|
artikel
|
| 116 |
MTADV 5-MER PEPTIDE SUPPRESSES IBD PATHOLOGY AND UNVEILS A NEW POTENTIAL TARGET-SERUM AMYLOID A
|
Naor, David
|
|
|
162 |
3S |
p. S6
|
artikel
|
| 117 |
MY SCD PROTOCOL - AN ONLINE, COMPREHENSIVE, REMOTELY-SUPERVISED PROTOCOL FOR IBD PATIENTS TO IMPLEMENT AN EFFECTIVE DIETARY INTERVENTION
|
Arjomand, Ali
|
|
|
162 |
3S |
p. S26-S27
|
artikel
|
| 118 |
NEW OXPHOS REGULATING COMPOUND – AUPHOS – INCREASES MITOCHONDRIAL COMPLEXES EXPRESSION IN MURINE AND HUMAN INTESTINAL EPITHELIAL CELLS
|
Elsayed, Ahmed
|
|
|
162 |
3S |
p. S51
|
artikel
|
| 119 |
NIPEP-IBD; A SYNTHETIC PEPTIDE TARGETING NOVEL MOLECULE, INTEGRIN BETA 1, TO RESTITUTE INTESTINAL EPITHELIAL CELLS FOR INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT
|
Kim, Deogil
|
|
|
162 |
3S |
p. S64
|
artikel
|
| 120 |
NOD2 PROMOTES HOST DEFENSE AND RECOVERY INDUCING MACROPHAGE-MEDIATED INNATE LYMPHOID CELLS TYPE 3 ACTIVATION FOLLOWING FUNGAL INFECTION IN EXPERIMENTAL COLITIS
|
McAndrew, Morgan
|
|
|
162 |
3S |
p. S59
|
artikel
|
| 121 |
NON-IMMUNE MEDIATED MUSCULOSKELETAL DISEASE IN CROHN'S DISEASE PATIENTS BEING EVALUATED FOR INFLAMMATORY SPONDYLOARTHRITIS - A PILOT STUDY
|
Schwartzman, Monica
|
|
|
162 |
3S |
p. S41-S42
|
artikel
|
| 122 |
NON-IMMUNE MEDIATED MUSCULOSKELETAL DISEASE IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW OF THE LITERATURE
|
Schwartzman, Monica
|
|
|
162 |
3S |
p. S42
|
artikel
|
| 123 |
NOVEL CONTRIBUTIONS OF CLAUDIN-4 TO EPITHELIAL BARRIER REGULATION AND COLITIS
|
Shashikanth, Nitesh
|
|
|
162 |
3S |
p. S51-S52
|
artikel
|
| 124 |
NOVEL FUNCTION OF MYELOID METHYLTRANSFERASE SMYD5 IN INFLAMMATORY BOWEL DISEASE PROGRESSION
|
Hou, Yuning
|
|
|
162 |
3S |
p. S59-S60
|
artikel
|
| 125 |
NOVEL INSIGHTS INTO THE MECHANISM OF ACTION OF EXCLUSIVE ENTERAL NUTRITION IN CROHN’S DISEASE: PRE-CLINICAL STUDY IN A RODENT MODEL OF CROHN’S-LIKE COLITIS
|
Geesala, Ramasatyaveni
|
|
|
162 |
3S |
p. S27-S28
|
artikel
|
| 126 |
ORAL ADMINISTRATION OF NANOLIPOSOMES LOADED M13 MAY TREAT ULCERATIVE COLITIS AND COLITIS-ASSOCIATED CANCER WITHOUT CAUSING ANY SIDE EFFECTS
|
Long, Dingpei
|
|
|
162 |
3S |
p. S6-S7
|
artikel
|
| 127 |
OUTCOMES OF TOTAL PROCTOCOLECTOMY (TPC) WITH ILEAL POUCH ANAL ANASTOMOSIS (IPAA)
|
Petrov, Jessica
|
|
|
162 |
3S |
p. S75-S76
|
artikel
|
| 128 |
OXPHOS DRIVES CRYPT FISSIONING REQUIRED FOR HEALING OF IBD ULCERS
|
Abomhya, Ahmed
|
|
|
162 |
3S |
p. S52
|
artikel
|
| 129 |
PAIN IN INFLAMMATORY BOWEL DISEASE (IBD): DOES OPIOID USE PREDICT WORSE HOSPITAL OUTCOMES?
|
Dasu, Neethi
|
|
|
162 |
3S |
p. S42-S43
|
artikel
|
| 130 |
PATIENTS' PERSPECTIVES, EXPERIENCES, AND CONCERNS WITH CROHN'S PERIANAL FISTULAE: INSIGHTS FROM SOCIAL MEDIA PLATFORMS
|
Khalil, Carine
|
|
|
162 |
3S |
p. S92-S93
|
artikel
|
| 131 |
PEOPLE WITH IBD WANT TO TALK ABOUT SLEEP: RECOMMENDATIONS ON WHAT TO ASK AND HOW TO RESPOND TO SLEEP COMPLAINTS
|
Salwen-Deremer, Jessica
|
|
|
162 |
3S |
p. S93
|
artikel
|
| 132 |
PLIN2 IS AN ARYL HYDROCARBON RECEPTOR TRANSCRIPTIONAL TARGET AND MAY CONTRIBUTE TO MUCOSAL RESTITUTION
|
Davis, Deanna
|
|
|
162 |
3S |
p. S52-S53
|
artikel
|
| 133 |
POINT-OF-CARE INTESTINAL ULTRASOUND FOR THE DETECTION OF POSTOPERATIVE CROHN'S DISEASE ENDOSCOPIC RECURRENCE
|
Dolinger, Michael
|
|
|
162 |
3S |
p. S34-S35
|
artikel
|
| 134 |
POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS OF OZANIMOD IN ULCERATIVE COLITIS
|
Tatosian, Daniel
|
|
|
162 |
3S |
p. S16
|
artikel
|
| 135 |
POPULATION PHARMACOKINETICS OF OZANIMOD AND ACTIVE METABOLITE CC112273 IN PATIENTS WITH ULCERATIVE COLITIS
|
Shen, Jun
|
|
|
162 |
3S |
p. S17-S18
|
artikel
|
| 136 |
PPI ADMINISTRATION CAUSES COLONIC TIGHT JUNCTION BARRIER DYSFUNCTION VIA INCREASE IN ENETROCOCCUS FECALIS
|
Nighot, Meghali
|
|
|
162 |
3S |
p. S53
|
artikel
|
| 137 |
PREDICTIVE PERFORMANCE OF DIFFERENT POPULATION PHARMACOKINETIC MODELS IN A REAL-WORLD COHORT OF CROHN’S DISEASE PATIENTS
|
Samuels, Abigail
|
|
|
162 |
3S |
p. S99-S100
|
artikel
|
| 138 |
PREDICTORS AND OUTCOMES OF BIOLOGIC/IMMUNOSUPPRESSIVE THERAPY FOR PSC-ASSOCIATED IBD
|
Sayed, Amr
|
|
|
162 |
3S |
p. S76
|
artikel
|
| 139 |
PREDICTORS OF CLINICAL RELAPSE AMONG PATIENTS WITH ULCERATIVE COLITIS IN ENDO-HISTOLOGIC REMISSION
|
Zeina, Tanya
|
|
|
162 |
3S |
p. S47-S48
|
artikel
|
| 140 |
PREVALENCE AND IMPACTS OF POST-TRAUMATIC STRESS SYMPTOMS IN IBD PATIENTS FROM UNDER-REPRESENTED MINORY GROUPS
|
McGarva, Josie
|
|
|
162 |
3S |
p. S93-S94
|
artikel
|
| 141 |
PROMOTING AT-HOME DISEASE MANAGEMENT OF IBD WITH A MULTIDISCIPLINARY DIGITAL THERAPY APP: SHORT-TERM RESULTS
|
Pater, Roeland
|
|
|
162 |
3S |
p. S94
|
artikel
|
| 142 |
RANDOMIZED, DOUBLE-BLIND, PLACEBO (PBO)-CONTROLLED, SINGLE- AND MULTIPLE-DOSE PHASE 1 STUDY OF VE202, A DEFINED BACTERIAL CONSORTIUM FOR TREATMENT OF IBD: SAFETY AND COLONIZATION DYNAMICS OF A NOVEL LIVE BIOTHERAPEUTIC PRODUCT (LBP) IN HEALTHY ADULTS
|
Silber, Jeffrey
|
|
|
162 |
3S |
p. S65-S66
|
artikel
|
| 143 |
REAL-TIME CONTINUOUS REPORTING OF IBD BIOMARKERS IN SWEAT
|
Jagannath, Badrinath
|
|
|
162 |
3S |
p. S21
|
artikel
|
| 144 |
REAL WORLD EFFECTIVENESS AND SAFETY OF OZANIMOD: INITIAL RESULTS FROM A LARGE TERTIARY CENTER
|
Cohen, Nathaniel
|
|
|
162 |
3S |
p. S109
|
artikel
|
| 145 |
REAL-WORLD UTILIZATION OF ADALIMUMAB BIOSIMILAR (ABP 501) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN EUROPE
|
Jin, Ran
|
|
|
162 |
3S |
p. S109-S110
|
artikel
|
| 146 |
REAL-WORLD VEDOLIZUMAB PHARMACOKINETIC STUDY IN CHILDREN IDENTIFIES TWO NOVEL BIOMARKERS OF DRUG CLEARANCE
|
Colman, Ruben
|
|
|
162 |
3S |
p. S100
|
artikel
|
| 147 |
REDEFINING HEALTHCARE: A NOVEL, SCIENCE-BASED, EXPERIENTIAL FRAMEWORK FOR IMPROVING PATIENT OUTCOMES IN INFLAMMATORY BOWEL DISEASE
|
Puckett, Amanda
|
|
|
162 |
3S |
p. S94-S95
|
artikel
|
| 148 |
RELATIONSHIP BETWEEN SELF-REPORTED SLEEP AND DISEASE ACTIVITY DIFFERS BASED ON ENDOSCOPIC OR CLINICAL DISEASE ACTIVITY MEASURES
|
Kamp, Kendra
|
|
|
162 |
3S |
p. S77
|
artikel
|
| 149 |
RISK FACTORS FOR DEVELOPMENT OF PROSTATE CANCER IN PATIENT WITH INFLAMMATORY BOWEL DISEASE (IBD)
|
Jakhar, Ishaan
|
|
|
162 |
3S |
p. S21-S22
|
artikel
|
| 150 |
SAFETY AND EFFECTIVENESS OF THE BNT162B2 MRNA COVID-19 VACCINE IN A NATIONWIDE COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
|
Khan, Muhammad
|
|
|
162 |
3S |
p. S12-S13
|
artikel
|
| 151 |
SAFFRON AS AN ADJUVANT THERAPY IN ULCERATIVE COLITIS PATIENTS
|
Ashktorab, Hassan
|
|
|
162 |
3S |
p. S18
|
artikel
|
| 152 |
SECURE ELECTRONIC DOCUMENT SIGNING UPTAKE IN BIOLOGIC PRESCRIBING FOR IMMUNE MEDIATED DISEASES
|
Sharma, Sowmya
|
|
|
162 |
3S |
p. S86
|
artikel
|
| 153 |
SELECTION OF MICROBIOME-DERIVED PEPTIDES THROUGH MULTI-TECHNOLOGY META-ANALYSIS, BINDING, AND FUNCTIONAL ASSAYS, IDENTIFIES PEPTIDES WITH THERAPEUTIC POTENTIAL THAT MODULATE IMMUNE RESPONSES AND DISEASE
|
Lin, Michelle
|
|
|
162 |
3S |
p. S66
|
artikel
|
| 154 |
SELECTIVELY IMPROVEMENT OF THE RESPONSE OF IMMUNE CELLS TO OPPORTUNISTIC MICROORGANISMS: AN INNOVATIVE PROPOSAL FOR IBD FROM AN ANCIENT GRAIN
|
Segura, Sergio Pumarola
|
|
|
162 |
3S |
p. S28-S29
|
artikel
|
| 155 |
SELF-RATED HEALTH IN INFLAMMATORY BOWEL DISEASE CORRELATES WITH ANXIETY, DEPRESSION, CATASTROPHIC THINKING, AND DISEASE SEVERITY
|
Palmer, Brooke
|
|
|
162 |
3S |
p. S95-S96
|
artikel
|
| 156 |
SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY
|
Quan, Joshua
|
|
|
162 |
3S |
p. S48
|
artikel
|
| 157 |
SEXUAL DYSFUNCTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
|
Kaniewska, Magdalena
|
|
|
162 |
3S |
p. S96
|
artikel
|
| 158 |
SIMPLE SUGAR TRIGGERS SPONTANEOUS COLITIS DEVELOPMENT IN IL10 -/- MICE
|
Khan, Shahanshah
|
|
|
162 |
3S |
p. S29
|
artikel
|
| 159 |
STIGMA INTERNALIZATION IN NON-WHITE PATIENTS WITH IBD AND ITS RELATIONSHIP WITH PATIENT OUTCOMES
|
Veracruz, Nicolette
|
|
|
162 |
3S |
p. S96-S97
|
artikel
|
| 160 |
STIGMA PERCEPTIONS IN NON-WHITE IBD PATIENTS AND RELATIONSHIPS WITH PATIENT OUTCOMES
|
Veracruz, Nicolette
|
|
|
162 |
3S |
p. S97
|
artikel
|
| 161 |
SUCCESSFUL CLEARANCE OF CYTOMEGALOVIRUS COLITIS IN ACUTE SEVERE ULCERATIVE COLITIS DURING INDUCTION OF OZANIMOD
|
Mohamed, Rana
|
|
|
162 |
3S |
p. S110-S111
|
artikel
|
| 162 |
TH17 CELLS PROMOTE INTESTINAL FIBROSIS THROUGH THE PRODUCTION OF AMPHIREGULIN
|
Yang, Wenjing
|
|
|
162 |
3S |
p. S64
|
artikel
|
| 163 |
THE ASSESSMENT OF MRE FINDINGS ACCORDING TO CDAI SCORE IN PATIENTS WITH CROHN’S DISEASE
|
Zbroja, Monika
|
|
|
162 |
3S |
p. S22
|
artikel
|
| 164 |
THE CROHN'S AND COLITIS DISTRESS SCALE: ASSESSING THE DOMAINS OF IMPACT IN YOUTH WITH IBD
|
Cummings, Caroline
|
|
|
162 |
3S |
p. S97
|
artikel
|
| 165 |
THE EFFECTS OF HIGH-FAT, LOW-FAT, AND SUCROSE-FREE DIETS ON MICE WITH INNATE IMMUNE MEDIATED COLITIS
|
Ruley-Haase, Katelyn
|
|
|
162 |
3S |
p. S29-S30
|
artikel
|
| 166 |
THE IMPACT OF CARDIAC ARRHYTHMIAS ON INFLAMMATORY BOWEL DISEASE (IBD)
|
Dasu, Neethi
|
|
|
162 |
3S |
p. S43
|
artikel
|
| 167 |
THE MICROBIAL LANDSCAPE OF ULCERATIVE COLITIS IN ENDOSCOPIC REMISSION
|
Jangi, Sushrut
|
|
|
162 |
3S |
p. S69-S70
|
artikel
|
| 168 |
THE OPIOID EPIDEMIC: ASSESSING OUTCOMES OF OPIOID ABUSE IN CHRONIC INFLAMMATORY DISEASE (ULCERATIVE COLITIS VS CROHN'S DISEASE)
|
Dasu, Neethi
|
|
|
162 |
3S |
p. S43-S44
|
artikel
|
| 169 |
THE ROLE OF GROUP 3 INNATE LYMPHOID CELLS (ILC3) IN GM-CSF/CSF2RB-DEPENDENT INTESTINAL HOMEOSTASIS IN CROHN’S DISEASE
|
Chuang, Ling-shiang
|
|
|
162 |
3S |
p. S60
|
artikel
|
| 170 |
THE SYNTHETIC GLYCAN KB295 OPTIMIZES MICROBIOME COMPOSITION AND FUNCTION IN ULCERATIVE COLITIS – RESULTS FROM A PROOF OF PRINCIPLE HUMAN STUDY
|
Meisner, Jeffrey
|
|
|
162 |
3S |
p. S70-S71
|
artikel
|
| 171 |
THE USE OF IMMUNOSTAINING IN BIOPSIES TO EVALUATE EXPRESSION PATTERN AND PATHOPHYSIOLOGY ROLES OF ONCOSTATIN M AND ITS RECEPTOR BETA IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
|
Beri, Jonathan
|
|
|
162 |
3S |
p. S19
|
artikel
|
| 172 |
TNFAIP3 DRIVES COLITIS THROUGH DEATH CELL AND TNFα PRODUCTION
|
Torres Huerta, Alvaro
|
|
|
162 |
3S |
p. S61
|
artikel
|
| 173 |
TOFACITINIB TREATMENT PREVENTS POST-OPERATIVE RECURRENCE OF CROHN’S DISEASE MODELED BY ILEOCECAL RESECTION IN HLA-B27 TRANSGENIC RATS
|
Blondeaux, Aurélie
|
|
|
162 |
3S |
p. S7
|
artikel
|
| 174 |
TOWARDS A COMMON VALIDATED METHODOLOGY FOR HISTOLOGIC MEASUREMENT OF MUCOSAL HEALING IN ULCERATIVE COLITIS: INTRODUCING A NEW PROJECT OF THE BIOMARKERS CONSORTIUM OF THE FOUNDATION FOR THE NIH
|
Honig, Gerard
|
|
|
162 |
3S |
p. S35
|
artikel
|
| 175 |
TRANSPORTATION ACCESS AND DELAY IN DIAGNOSIS FOR PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS
|
Zeky, Nicole
|
|
|
162 |
3S |
p. S98
|
artikel
|
| 176 |
TRENDS IN ADMISSIONS, OUTCOMES AND FINANCIAL BURDEN OF C. DIFFICILE INFECTION RELATED HOSPITALIZATIONS AMONG INFLAMMATORY BOWEL DISEASE PATIENTS: A NATIONWIDE ANALYSIS
|
Tahir, Muhammad Waqas
|
|
|
162 |
3S |
p. S71
|
artikel
|
| 177 |
UHPLC-MS/MS-BASED PLASMA LIPIDOMICS REVEAL ALTERATIONS ASSOCIATED WITH EXCLUSIVE ENTERAL NUTRITION TREATMENT IN ADULT PATIENTS WITH ACTIVE CROHN’S DISEASE
|
Yang, Qingfan
|
|
|
162 |
3S |
p. S77-S78
|
artikel
|
| 178 |
UTILITY OF FIBROSCAN IN ULCERATIVE COLITIS?
|
Jain, Shubham
|
|
|
162 |
3S |
p. S22-S23
|
artikel
|
| 179 |
VALIDATION OF THE SIMPLIFIED ENDOSCOPIC MUCOSAL ASSESSMENT OF CROHN’S DISEASE (SEMA-CD) A NOVEL ENDPOINT TO ASSESS ENDOSCOPIC IMPROVEMENT WITH REAL WORLD DATA
|
Adler, Jeremy
|
|
|
162 |
3S |
p. S35-S36
|
artikel
|
| 180 |
VEDOLIZUMAB AS TREATMENT FOR COMMON VARIABLE IMMUNE DEFICIENCY (CVID): A CASE SERIES AND BRIEF REVIEW OF THE LITERATURE
|
Patel, Sagar
|
|
|
162 |
3S |
p. S111
|
artikel
|
| 181 |
VEDOLIZUMAB FOR REFRACTORY MICROSCOPIC COLITIS: A CASE SERIES
|
Dawoud, Nabila
|
|
|
162 |
3S |
p. S112
|
artikel
|
| 182 |
WHEN CROHN'S COMES TO RADIOLOGIST- THE ROLE OF MR ENTEROGRAPHY (MRE) IN THE DIAGNOSIS OF PENETRATING CROHN'S DISEASE IN PEDIATRIC AND ADULT PATIENTS
|
Cyranka, Weronika
|
|
|
162 |
3S |
p. S23
|
artikel
|
| 183 |
WITHDRAWN: EFFICACY, SAFETY, AND TOLERABILITY OF OMILANCOR IN A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PATIENTS WITH ULCERATIVE COLITIS
|
Leber, Andrew
|
|
|
162 |
3S |
p. S112
|
artikel
|
Tijdschrift beschrijving